XOMA Corp (XOMA.OQ)
XOMA.OQ on NASDAQ Stock Exchange Global Market
5.43USD
10:55am EDT
5.43USD
10:55am EDT
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$5.43
$5.43
Open
$5.49
$5.49
Day's High
$5.49
$5.49
Day's Low
$5.39
$5.39
Volume
37,650
37,650
Avg. Vol
227,116
227,116
52-wk High
$5.53
$5.53
52-wk Low
$2.37
$2.37
About
XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company’s preclinica... (more)
Overall
| Beta: | 2.26 |
| Market Cap (Mil.): | $450.11 |
| Shares Outstanding (Mil.): | 82.89 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| XOMA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.90 | -- | -- |
| ROI: | -86.05 | -2.58 | 18.76 |
| ROE: | -705.39 | -2.66 | 19.59 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

